Madison’s Deltanoid Names New CEO, Replacing UW Legend DeLuca

Xconomy Wisconsin — 

Madison, WI-based Deltanoid Pharmaceuticals has named former Genzyme executive Douglas Jermasek as its new CEO. Jermasek will replace Hector DeLuca, who has spent his life researching Vitamin D and building companies based on the compound. Xconomy profiled DeLuca and Deltanoid in late 2014. DeLuca becomes Deltanoid’s chairman, president and COO.